Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO
Official title: COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO
Status: Enrolling by invitation
Description:
Patient of stable and limited vitiligo less than 20% BSA will be recruited And evaluation of efficacy and safety of narrowband UVB with topical tacrolimus vs narrowband UVB and calcipotriol will be assessed
Phase: Early Phase 1.
What is being studied: drugs — Tacrolimus, Calcipotriol.
Who can take part: ages 15 Years to 70 Years, 60 participants planned.
Enrollment status: the registry has not updated this study since its planned completion date, so its current status is unclear. The study started 01 May 2025 and was due to finish 30 August 2025.
Source: ClinicalTrials.gov, NCT06880042 (https://clinicaltrials.gov/study/NCT06880042).
Start date: May 01, 2025
Completion date: August 30, 2025
Organizer: Dr ayesha wahid
Link: https://clinicaltrials.gov/study/NCT06880042
The registry does not list a contact for this study. Use the link above to reach the study record on ClinicalTrials.gov.
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- How long does it take to treat vitiligo?
Vitiligo, a condition characterized by the loss of skin pigment, can be unpredictable in both progression and treatment. The time it takes to treat vitiligo varies significantly...
- I have a new job - should I tell colleagues about my vitiligo?
Starting a new job can be both exciting and nerve-wracking, — especially if you’re concerned about stares or questions regarding your skin. Taking a proactive approach can help ...
- How Vitiligo Changes with Age?
Vitiligo, a condition characterized by the loss of skin pigmentation, can affect individuals at any stage of life. While it often appears before the age of 20, its progression a...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.